Connection

Marc Chimowitz to Intracranial Arteriosclerosis

Back to Details
This is a "connection" page, showing publications Marc Chimowitz has written about Intracranial Arteriosclerosis.
Marc Chimowitz
Connection Strength
11.307
Intracranial Arteriosclerosis
  1. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022 04; 21(4):355-368.
    View in: PubMed
    Score: 0.673
  2. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105254.
    View in: PubMed
    Score: 0.610
  3. Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
    View in: PubMed
    Score: 0.587
  4. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res. 2017 Feb 03; 120(3):502-513.
    View in: PubMed
    Score: 0.475
  5. Angioplasty and Stenting. Front Neurol Neurosci. 2016; 40:152-163.
    View in: PubMed
    Score: 0.470
  6. Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2014; 37(6):417-22.
    View in: PubMed
    Score: 0.397
  7. Is calcification of intracranial arteries important and how? JAMA Neurol. 2014 Apr; 71(4):401-2.
    View in: PubMed
    Score: 0.390
  8. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists. Cerebrovasc Dis. 2014; 37(3):203-11.
    View in: PubMed
    Score: 0.387
  9. In reply: Is there a contribution of anesthesia to the outcome of the SAMMPRIS trial? Neurosurgery. 2014 Feb; 74(2):E235-6.
    View in: PubMed
    Score: 0.386
  10. The challenge of stroke prevention with intracranial arterial stenosis. Curr Cardiol Rep. 2013 Dec; 15(12):422.
    View in: PubMed
    Score: 0.381
  11. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013 Nov; 12(11):1106-14.
    View in: PubMed
    Score: 0.379
  12. The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future. Stroke. 2013 Sep; 44(9):2664-9.
    View in: PubMed
    Score: 0.371
  13. Intracranial stenting: SAMMPRIS. Stroke. 2013 Jun; 44(6 Suppl 1):S41-4.
    View in: PubMed
    Score: 0.368
  14. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 Sep 15; 365(11):993-1003.
    View in: PubMed
    Score: 0.327
  15. Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis. Cerebrovasc Dis. 2011; 31(6):588-91.
    View in: PubMed
    Score: 0.318
  16. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2011 Apr; 21(2):e159-61.
    View in: PubMed
    Score: 0.317
  17. 10 questions about intracranial atherosclerotic stenosis. Neurologist. 2010 Nov; 16(6):400-5.
    View in: PubMed
    Score: 0.308
  18. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg. 2009 Jul; 1(1):35-9.
    View in: PubMed
    Score: 0.281
  19. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009 Mar; 40(3):719-25.
    View in: PubMed
    Score: 0.267
  20. Re: Turk et al and the "how do we spin wingspan?" commentary. AJNR Am J Neuroradiol. 2008 Sep; 29(8):e69; author reply e70.
    View in: PubMed
    Score: 0.258
  21. Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis. 2008; 5(3):117-24.
    View in: PubMed
    Score: 0.253
  22. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am. 2007 Aug; 17(3):355-63, viii-ix.
    View in: PubMed
    Score: 0.246
  23. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005 Mar 31; 352(13):1305-16.
    View in: PubMed
    Score: 0.209
  24. Antithrombotic therapy for atherosclerotic intracranial arterial stenosis. Adv Neurol. 2003; 92:271-4.
    View in: PubMed
    Score: 0.179
  25. Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China. Lancet Neurol. 2022 Dec; 21(12):1089-1098.
    View in: PubMed
    Score: 0.177
  26. Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee. Neurology. 2022 03 22; 98(12):486-498.
    View in: PubMed
    Score: 0.170
  27. Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study. J Stroke Cerebrovasc Dis. 2021 Feb; 30(2):105504.
    View in: PubMed
    Score: 0.155
  28. Mechanisms of early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Rationale and design. J Stroke Cerebrovasc Dis. 2020 Oct; 29(10):105051.
    View in: PubMed
    Score: 0.151
  29. Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovasc Dis. 2019; 47(1-2):24-31.
    View in: PubMed
    Score: 0.137
  30. Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2018 Mar; 27(3):801-805.
    View in: PubMed
    Score: 0.126
  31. Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis. 2017; 43(1-2):31-35.
    View in: PubMed
    Score: 0.117
  32. Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. J Stroke Cerebrovasc Dis. 2017 Jan; 26(1):108-115.
    View in: PubMed
    Score: 0.116
  33. Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016 Jan; 73(1):36-42.
    View in: PubMed
    Score: 0.110
  34. Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design. Brain Behav. 2015 Dec; 5(12):e00397.
    View in: PubMed
    Score: 0.108
  35. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis. Stroke. 2015 Mar; 46(3):775-9.
    View in: PubMed
    Score: 0.103
  36. Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. J Neuroimaging. 2015 Jan-Feb; 25(1):87-91.
    View in: PubMed
    Score: 0.097
  37. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014 Jan 25; 383(9914):333-41.
    View in: PubMed
    Score: 0.095
  38. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013 May; 72(5):777-95; discussion 795.
    View in: PubMed
    Score: 0.092
  39. Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60.
    View in: PubMed
    Score: 0.087
  40. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011 Jun; 69(6):963-74.
    View in: PubMed
    Score: 0.079
  41. Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab. 2011 May; 31(5):1293-301.
    View in: PubMed
    Score: 0.078
  42. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol. 2008 Jun; 65(6):733-7.
    View in: PubMed
    Score: 0.065
  43. Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke. 2008 Mar; 39(3):1039-41.
    View in: PubMed
    Score: 0.064
  44. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008 Apr 22; 70(17):1518-24.
    View in: PubMed
    Score: 0.064
  45. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007 Nov 27; 69(22):2063-8.
    View in: PubMed
    Score: 0.063
  46. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007; 24(2-3):283-8.
    View in: PubMed
    Score: 0.061
  47. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology. 2007 Jun 12; 68(24):2099-106.
    View in: PubMed
    Score: 0.060
  48. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology. 2006 May 09; 66(9):1344-9.
    View in: PubMed
    Score: 0.056
  49. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol. 1992 Jul; 49(7):747-52.
    View in: PubMed
    Score: 0.022
  50. Mechanism of stroke in patients taking aspirin. Neurology. 1990 Nov; 40(11):1682-5.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.